{"nct_id":"NCT03976102","title":"Compare Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in LTB Follicular Lymphoma","status":"COMPLETED","status_verified_date":"2024-01","start_date":"2019-05-15","start_date_type":"ACTUAL","primary_completion_date":"2022-09-28","primary_completion_date_type":"ACTUAL","completion_date":"2023-02-27","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["RDY"]}